about
Drug nanocrystals: A way toward scale-upClinical updates on carvedilol: a first choice beta-blocker in the treatment of cardiovascular diseasesImproved Aqueous Solubility and Antihypercholesterolemic Activity of Ezetimibe on Formulating with Hydroxypropyl-β-Cyclodextrin and Hydrophilic Auxiliary Substances.Stomach-site specific drug delivery system of clarithromycin for eradication of Helicobacter pylori.Study of polymorphs of progesterone by novel melt sonocrystallization technique: a technical note.Methotrexate: a detailed review on drug delivery and clinical aspects.Doxofylline: a promising methylxanthine derivative for the treatment of asthma and chronic obstructive pulmonary disease.Polylactide-co-glycolide nanoparticles of antitubercular drugs: formulation, characterization and biodistribution studies.Preparation and characterization of isoniazid and lamivudine co-loaded polymeric microspheres.Colon targeted drug delivery systems--an overview.An overview of recent patents on oral osmotic drug delivery systems.Comparative in vitro and in vivo evaluation of matrix, osmotic matrix, and osmotic pump tablets for controlled delivery of diclofenac sodium.Colloidal nanocarriers: a review on formulation technology, types and applications toward targeted drug delivery.Lipid-based oral multiparticulate formulations - advantages, technological advances and industrial applications.Drug nanocrystals: four basic prerequisites for formulation development and scale-up.Macrophage-specific targeting of isoniazid through mannosylated gelatin microspheres.Advances in patents related to intrapocket technology for the management of periodontitis.Design, optimization and characterizations of chitosan fortified calcium alginate microspheres for the controlled delivery of dual drugs.Development of long-circulating docetaxel loaded poly (3-hydroxybutyrate-co-3-hydroxyvalerate) nanoparticles: Optimization, pharmacokinetic, cytotoxicity and in vivo assessments.Long-circulating polyhydroxybutyrate-co-hydroxyvalerate nanoparticles for tumor targeted docetaxel delivery: Formulation, optimization and in vitro characterization.Tinidazole functionalized homogeneous electrospun chitosan/poly (ε-caprolactone) hybrid nanofiber membrane: Development, optimization and its clinical implications.Transition from passive to active targeting of oral insulin nanomedicines: enhancement in bioavailability and glycemic control in diabetes.Curcumin-polymeric nanoparticles against colon-26 tumor-bearing mice: cytotoxicity, pharmacokinetic and anticancer efficacy studies.Design of novel chemotherapeutic delivery systems for colon cancer therapy based on oral polymeric nanoparticles.Floating elementary osmotic pump tablet (FEOPT) for controlled delivery of diethylcarbamazine citrate: a water-soluble drugCurcumin Quantum Dots Mediated Degradation of Bacterial Biofilms.Development and Evaluation of Biodegradable Chitosan Films of Metronidazole and Levofloxacin for the Management of Periodontitis.Investigation of organoleptic characteristics in the development of soft chews of calcium carbonate as mineral supplement.Assessment of solubilization characteristics of different surfactants for carvedilol phosphate as a function of pH.Mannose-conjugated chitosan nanoparticles loaded with rifampicin for the treatment of visceral leishmaniasis.Metabolism and excretion of centbutindole (neuroleptic) in rats after oral administration.Fabrication and evaluation of taste masked resinate of risperidone and its orally disintegrating tablets.Formulation and evaluation of clarithromycin microspheres for eradication of Helicobacter pylori.Colon targeted delivery systems of metronidazole based on osmotic technology: development and evaluation.Gastroretentive drug delivery system of metoclopramide hydrochloride: formulation and in vitro evaluation.Evaluation of in vivo behavior of controlled and pulsatile release pastilles using pharmacokinetic and γ-scintigraphic techniques.Process optimization and in vivo performance of docetaxel loaded PHBV-TPGS therapeutic vesicles: A synergistic approach.Development, optimization, and in vitro characterization of dasatinib-loaded PEG functionalized chitosan capped gold nanoparticles using Box-Behnken experimental design.Development and optimization of locust bean gum and sodium alginate interpenetrating polymeric network of capecitabine.Preparation and pharmacodynamic assessment of ezetimibe nanocrystals: Effect of P-gp inhibitory stabilizer on particle size and oral absorption.
P50
Q26744024-40DE34D4-27BF-4267-ABBB-941344F9EC89Q28270431-FDB353C1-8755-4337-9AA9-D38FD0BC66C1Q30972375-5DFAE380-39AB-4788-921C-C924726E1C0BQ33508426-8FDC67A5-D8BB-4F15-8E72-E025D5C4058EQ33698254-0F6DC99D-E1D3-486E-A7A4-A75FDD956100Q34247680-267E7AA4-3907-43B6-9B57-F87219654177Q34997202-E1457874-D5C8-4EC7-90EB-30EF23B8CCD7Q35532338-16D3008F-FD79-4E7D-8A3A-5C58A39D8495Q35859595-E30146B5-A844-48E8-9F41-082A1BEDD37BQ37233034-A91E6210-2EFA-477D-B88A-78C78967B1B0Q37347816-49545D55-C0B3-45A1-BBF5-5F9FD381F105Q37360765-C42E580C-DDE5-4828-9D44-A76F71B249C8Q37485041-33D6EB29-A889-44E1-B619-4C9A26202944Q37826428-779BDB93-F3EE-40C0-A189-22B4439E6AD5Q38269719-9F3A3F7D-DD81-48BB-BF83-BB4FB0456414Q38311993-D1F530A9-B1C4-46E7-BD5F-C4FA5B8F4ECAQ38373778-814F4120-1DBC-4BA4-91DC-F729F0BDB5F7Q38613852-591857EC-A9A5-4956-9FE6-C30D8E67F093Q38702499-5F917EEB-5313-4BE3-94CF-08F83A409C58Q38724962-DE2A842F-B269-41E7-AC86-AC4D06D4DD9AQ38742254-A7069C03-B91A-43B1-84BB-885E8AE610E7Q38832783-5ECA75B3-5FC1-4B73-99FB-2459C3F6D93CQ38854189-55AF7652-1508-4DDB-88C6-D267AEB84607Q39041183-F93DB808-9585-49E0-BC75-023171269408Q39422869-B22EE442-7192-4300-80DA-1F5E898C82D1Q40076746-27B0BBE2-7382-4040-B31A-9F2F8AF99C48Q40186882-7F7ABAFA-E537-4C24-8676-C1FBD0AC4CB9Q43232571-57760D80-1169-4C98-9345-1262950DF513Q43644696-89DC83B1-0267-48AA-B0E4-BF6B41823E82Q44041983-D994C44F-B0B5-4016-AF1C-02A07F807510Q44287968-F900CE4E-EC06-4DE4-9855-25E6E835B6B3Q46066461-C0F752F8-36B8-4CC7-A656-B899B6899031Q46222651-B621740A-3A91-4AA1-AB34-27A6CA600F82Q46403155-29FE58E4-2D42-48AF-A679-33F4A1125A4CQ46917033-FA1E349B-F95B-4C9F-A882-58836AB217F9Q47218974-CB5A502F-E46C-4580-A5EF-39BE3B622EE8Q47309057-262A04BB-8283-43FB-B8DA-67B8C22EAE3EQ47327036-F64C080C-F38E-44D0-BB75-4D389E058C7BQ47327071-192A0376-B761-4224-A728-D43659D95E14Q47364218-C478C039-2ED8-44AF-B207-860DF6878CF9
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Brahmeshwar Mishra
@ast
Brahmeshwar Mishra
@en
Brahmeshwar Mishra
@es
Brahmeshwar Mishra
@nl
Brahmeshwar Mishra
@sl
type
label
Brahmeshwar Mishra
@ast
Brahmeshwar Mishra
@en
Brahmeshwar Mishra
@es
Brahmeshwar Mishra
@nl
Brahmeshwar Mishra
@sl
prefLabel
Brahmeshwar Mishra
@ast
Brahmeshwar Mishra
@en
Brahmeshwar Mishra
@es
Brahmeshwar Mishra
@nl
Brahmeshwar Mishra
@sl
P106
P31
P496
0000-0002-8608-2611